Literature DB >> 28286879

Dynamic Contrast-Enhanced Magnetic Resonance Enterography and Dynamic Contrast-Enhanced Ultrasonography in Crohn's Disease: An Observational Comparison Study.

Rune Wilkens1, David A Peters2, Agnete H Nielsen3, Valeriya P Hovgaard3, Henning Glerup3, Klaus Krogh4.   

Abstract

Purpose e Cross-sectional imaging methods are important for objective evaluationof small intestinal inflammationinCrohn'sdisease(CD).The primary aim was to compare relative parameters of intestinal perfusion between contrast-enhanced ultrasonography (CEUS) and dynamic contrast-enhanced magnetic resonance enterography (DCE-MRE) in CD. Furthermore, we aimed at testing the repeatability of regions of interest (ROIs) for CEUS. Methods This prospective study included 25 patients: 12 females (age: 37, range: 19-66) with moderate to severe CD and a bowel wall thickness>3mm evaluated with DCE-MRE and CEUS. CEUS bolus injection was performed twice for repeatability and analyzed in VueBox®. Correlations between modalities were described with Spearman's rho, limits of agreement(LoA) and intraclass correlation coefficient(ICC). ROIrepeatability for CEUS was assessed. Results s The correlation between modalities was good and very good for bowel wall thickness (ICC=0.71, P<0.001) and length of the inflamed segment (ICC=0.89, P<0.001). Moderate-weak correlations were found for the time-intensity curve parameters: peak intensity (r=0.59, P=0.006), maximum wash-in-rate (r=0.62, P=0.004), and wash-in perfusion index (r=0.47, P=0.036). Best CEUS repeatability for peak enhancement was a mean difference of 0.73 dB (95% CI: 0.17 to 1.28, P=0.01) and 95% LoA from -3.8 to 5.3 dB. Good quality of curve fit improved LoA to -2.3 to 2.8 dB. Conclusion The relative perfusion of small intestinal CD assessed with DCE-MRE and CEUS shows only a moderate correlation. Applying strict criteria for ROIs is important and allows for good CEUS repeatability.

Entities:  

Keywords:  Crohn’s disease; contrast media; magnetic resonance imaging; reproducibility of results; ultrasonography

Year:  2017        PMID: 28286879      PMCID: PMC5340279          DOI: 10.1055/s-0042-123841

Source DB:  PubMed          Journal:  Ultrasound Int Open        ISSN: 2199-7152


  48 in total

1.  Crohn's disease activity: quantitative contrast-enhanced ultrasound assessment.

Authors:  Daniel D Wong; Geoff M Forbes; Marilyn Zelesco; Rose Mason; Janina Pawlik; Richard M Mendelson
Journal:  Abdom Imaging       Date:  2012-06

Review 2.  Subclassification of small bowel Crohn's disease using magnetic resonance enterography: a review using evidence-based medicine methodology.

Authors:  D J Murphy; A E Smyth; S H McEvoy; D J Gibson; G A Doherty; D E Malone
Journal:  Clin Radiol       Date:  2015-09-11       Impact factor: 2.350

3.  Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

Authors:  Mark S Silverberg; Jack Satsangi; Tariq Ahmad; Ian D R Arnott; Charles N Bernstein; Steven R Brant; Renzo Caprilli; Jean-Frédéric Colombel; Christoph Gasche; Karel Geboes; Derek P Jewell; Amir Karban; Edward V Loftus; A Salvador Peña; Robert H Riddell; David B Sachar; Stefan Schreiber; A Hillary Steinhart; Stephan R Targan; Severine Vermeire; B F Warren
Journal:  Can J Gastroenterol       Date:  2005-09       Impact factor: 3.522

4.  The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.

Authors:  F Piscaglia; C Nolsøe; C F Dietrich; D O Cosgrove; O H Gilja; M Bachmann Nielsen; T Albrecht; L Barozzi; M Bertolotto; O Catalano; M Claudon; D A Clevert; J M Correas; M D'Onofrio; F M Drudi; J Eyding; M Giovannini; M Hocke; A Ignee; E M Jung; A S Klauser; N Lassau; E Leen; G Mathis; A Saftoiu; G Seidel; P S Sidhu; G ter Haar; D Timmerman; H P Weskott
Journal:  Ultraschall Med       Date:  2011-08-26       Impact factor: 6.548

5.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Authors:  J Panes; Y Bouhnik; W Reinisch; J Stoker; S A Taylor; D C Baumgart; S Danese; S Halligan; B Marincek; C Matos; L Peyrin-Biroulet; J Rimola; G Rogler; G van Assche; S Ardizzone; A Ba-Ssalamah; M A Bali; D Bellini; L Biancone; F Castiglione; R Ehehalt; R Grassi; T Kucharzik; F Maccioni; G Maconi; F Magro; J Martín-Comín; G Morana; D Pendsé; S Sebastian; A Signore; D Tolan; J A Tielbeek; D Weishaupt; B Wiarda; A Laghi
Journal:  J Crohns Colitis       Date:  2013-04-11       Impact factor: 9.071

6.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.

Authors:  Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor
Journal:  Eur J Radiol       Date:  2011-09-15       Impact factor: 3.528

Review 7.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

8.  Effect of Standardised Scoring Conventions on Inter-rater Reliability in the Endoscopic Evaluation of Crohn's Disease.

Authors:  Elena Dubcenco; Guangyong Zou; Larry Stitt; Jeffrey P Baker; Khursheed N Jeejeebhoy; Gabor Kandel; Young-In Kim; Samir C Grover; John W D McDonald; Lisa M Shackelton; Reena Khanna; Geert D'Haens; William J Sandborn; Brian G Feagan; Barrett G Levesque
Journal:  J Crohns Colitis       Date:  2016-07-06       Impact factor: 9.071

9.  Bowel perfusion measured with dynamic contrast-enhanced ultrasound predicts treatment outcome in patients with Crohn's disease.

Authors:  Fredrik Saevik; Kim Nylund; Trygve Hausken; Svein Ødegaard; Odd H Gilja
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325

10.  Contrast Enhanced Abdominal Ultrasound in the Assessment of Ileal Inflammation in Crohn's Disease: A Comparison with MR Enterography.

Authors:  C S Horjus Talabur Horje; R Bruijnen; L Roovers; M J M Groenen; F B M Joosten; P J Wahab
Journal:  PLoS One       Date:  2015-08-31       Impact factor: 3.240

View more
  4 in total

1.  Contrast-enhanced ultrasonography in clinical practice in Crohn's disease: feasibility of destruction/replenishment method and software analysis.

Authors:  Andrea Giannetti; Marco Matergi; Marco Biscontri; Luca Franci
Journal:  J Ultrasound       Date:  2017-10-31

2.  Biomechanical Properties of Strictures in Crohn's Disease: Can Dynamic Contrast-Enhanced Ultrasonography and Magnetic Resonance Enterography Predict Stiffness?

Authors:  Rune Wilkens; Dong-Hua Liao; Hans Gregersen; Henning Glerup; David A Peters; Charlotte Buchard; Anders Tøttrup; Klaus Krogh
Journal:  Diagnostics (Basel)       Date:  2022-06-02

3.  Contrast enhanced ultrasound: comparing a novel modality to MRI to assess for bowel disease in pediatric Crohn's patients.

Authors:  Kiran Mudambi; Jesse Sandberg; Dorsey Bass; Erika Rubesova
Journal:  Transl Gastroenterol Hepatol       Date:  2020-04-05

4.  Magnetic resonance enterography and bowel ultrasonography in Saudi Arabian patients with Crohn's disease: A correlation study.

Authors:  Rani Ahmad; Ahmed Abduljabbar; Mohammad Wazzan; Rawan Thabit; Mahmoud Mosli; Omar I Saadah
Journal:  Saudi J Gastroenterol       Date:  2022 May-Jun       Impact factor: 3.214

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.